Literature DB >> 3259538

Resistance to cutaneous leishmaniasis in nude mice injected with L3T4+ T cells but not with Ly-2+ T cells.

H Moll1, R Scollay, G F Mitchell.   

Abstract

The importance of T cells in resistance to infection with the intracellular protozoan parasite Leishmania major is substantiated by the susceptibility to infection of athymic nude mice of both resistant and susceptible strains. However, the relative roles of different T cell subpopulations remain controversial. In order to address this issue, selected L3T4+ Ly-2- or L3T4- Ly-2+ T cell subpopulations from normal mice were adoptively transferred into athymic nude recipients of the same strain, and their capacity to mediate host-protective immunity against infection with L. major promastigotes was determined. In experiments with mice of different inbred strains, reconstitution with L3T4+ Ly-2- cells rendered the nude mice completely resistant to cutaneous leishmaniasis, whereas L3T4- Ly-2+ cells failed to do so. Partial protection in some recipients of large numbers of Ly-2+ cells could be ascribed to contamination of the transferred inoculum with L3T4+ cells. Thus, resistance to L. major infection in reconstituted nude mice can be promoted by L3T4+ T cells in the absence of detectable Ly-2+ T cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259538     DOI: 10.1038/icb.1988.7

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  10 in total

1.  Reduced numbers of CD4+ suppressor cells with subsequent expansion of CD8+ protective T cells as an explanation for the paradoxical state of enhanced resistance to Leishmania in T-cell deficient BALB/c mice.

Authors:  J O Hill
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

2.  Influence of parasite load on the ability of type 1 T cells to control Leishmania major infection.

Authors:  Brian Hondowicz; Phillip Scott
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

3.  Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major.

Authors:  H Moll; G F Mitchell; M J McConville; E Handman
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

4.  Expression of T-cell-associated serine proteinase 1 during murine Leishmania major infection correlates with susceptibility to disease.

Authors:  H Moll; C Müller; R Gillitzer; H Fuchs; M Röllinghoff; M M Simon; M D Kramer
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

Review 5.  Immunobiology of experimental leishmaniasis.

Authors:  I Müller; U Fruth; J A Louis
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

Review 6.  Regulation of CD8+ T cell responses to infection with parasitic protozoa.

Authors:  Kimberly A Jordan; Christopher A Hunter
Journal:  Exp Parasitol       Date:  2010-05-21       Impact factor: 2.011

7.  Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania.

Authors:  J O Hill; M Awwad; R J North
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

8.  T helper subset differentiation in the absence of invariant chain.

Authors:  D R Brown; K Swier; N H Moskowitz; M F Naujokas; R M Locksley; S L Reiner
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

9.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

Authors:  F P Heinzel; M D Sadick; B J Holaday; R L Coffman; R M Locksley
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

10.  Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis.

Authors:  Maritsa Margaroni; Maria Agallou; Evita Athanasiou; Olga Kammona; Costas Kiparissides; Catherine Gaitanaki; Evdokia Karagouni
Journal:  Int J Nanomedicine       Date:  2017-08-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.